购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Bombesin Receptor
    (1)
  • Others
    (2)
TargetMol | Tags 通过 货期 筛选
  • 35日内发货
    (1)
筛选
搜索结果
TargetMol产品目录中 "

rc-3095

"的结果
  • 抑制剂&激动剂
    4
    TargetMol | Inhibitors_Agonists
  • 多肽产品
    3
    TargetMol | Peptide_Products
  • RC-3095 TFA
    RC-3095 (TFA)
    TP17011217463-61-0
    RC-3095 TFA (RC-3095(TFA)) 是蛙皮素 胃泌素释放肽受体选择性拮抗剂。它能降低关节炎小鼠的胃氧化损伤,从而发挥保护作用。
    • ¥ 3710
    期货
    规格
    数量
  • RC-3095
    TP1470138147-78-1
    RC-3095, a selective GRPR antagonist, has been shown to have anti-inflammatory properties in different models of inflammation.
    • 待询
    规格
    数量
  • RC-3095 acetate
    TP2153162666-31-1
    RC-3095 acetate is an antagonist of bombesin gastrin-releasing peptide receptor (GRPR). It exerts protective effects by reducing gastric oxidative injury in the arthritic mice.
    • 待询
    规格
    数量
  • Neuromedin C (trifluoroacetate salt)
    T35669
    Neuromedin C is a bombesin-like neuropeptide that stimulates uterine smooth muscle contraction and the release of gastrin , somatostatin, and amylase in rats. Neuromedin C is a truncated form of gastrin-releasing peptide corresponding to the GRP amino acids 18-27. It inhibits GRP and bombesin binding to rat pancreatic membranes (IC50s = 0.4 and 2.2 nM, respectively), which can be reduced by sodium chloride and guanylyl imidodiphosphate . Neuromedin C induces scratching and mast cell degranulation in mice when administered intradermally at doses ranging from 1 to 300 nmol site, which is inhibited by the BB2 bombesin receptor agonist RC-3095 and reduced in mast cell-deficient mice. Neuromedin C (3.2 nmol kg, i.p.) reduces rat glucose consumption by approximately 50% for up to one hour.
    • 待估
    35日内发货
    规格
    数量